XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Operating activities:    
Net income $ 130,174 $ 124,201
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 108,632 105,721
Stock-based compensation expense 40,807 44,939
Deferred taxes (1,813) (49,414)
Loss from divested operations 0 2,075
Reduction in the carrying amount of operating lease right-of-use assets 43,256 42,556
Amortization and write-off of deferred financing fees 5,392 3,238
Amortization of deferred swap losses from de-designation 10,320 0
Changes in assets and liabilities:    
Fees receivable, net 261,124 140,841
Deferred commissions 31,255 22,974
Prepaid expenses and other current assets 14,202 16,734
Other assets (932) (49,524)
Deferred revenues (149,615) 47,923
Accounts payable and accrued and other liabilities (93,885) (189,186)
Cash provided by operating activities 398,917 263,078
Investing activities:    
Additions to property, equipment and leasehold improvements (45,865) (59,479)
Acquisitions - cash paid (net of cash acquired) 0 (2,295)
Cash used in investing activities (45,865) (61,774)
Financing activities:    
Proceeds from employee stock purchase plan 9,719 9,077
Proceeds from borrowings 800,000 5,000
Payments of deferred financing fees (10,516) 0
Proceeds from revolving credit facility 327,000 253,000
Payments on revolving credit facility (475,000) (316,000)
Payments on borrowings (853,094) (46,647)
Purchases of treasury stock (73,862) (46,558)
Cash used in financing activities (275,753) (142,128)
Net increase in cash and cash equivalents 77,299 59,176
Effects of exchange rates on cash and cash equivalents (1,502) 614
Cash and cash equivalents and restricted cash, beginning of period 280,836 158,663
Cash and cash equivalents, end of period $ 356,633 $ 218,453